Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
In an ongoing effort to quell the national opioid epidemic and provide better resources for recovering addicts, the Food and Drug Administration (FDA) has approved a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. “Given the scope of the epidemic of opioid addiction, we need to find innovative new ways to help those currently addicted live lives of sobriety with the assistance of medically assisted treatment. There are three approved drugs for helping treat opioid addiction. While we continue to pursue better medicines for the treatment of opioid use disorder, ... Read More
Preliminary results from a clinical trial show that patients taking the gout medication febuxostat (brand name Uloric) were at greater risk of heart-related death than patients taking another gout medication called allopurinol, the Food and Drug Administration (FDA) announced in a safety communication. The agency had ordered Uloric’s maker, Takeda Pharmaceuticals, to conduct a safety study when the medication was approved in 2009 to better understand its risks. The agency is still evaluating the data and will update the public once the final results are available from Takeda and a comprehensive review is conducted. Febuxostat already carries a warning about ... Read More
High cumulative doses of the sleep aid Ambien have been linked to Alzheimer’s disease in elderly individuals, according to a retrospective study published in the Journal of the American Geriatric Society. Ambien contains the active ingredient zolpidem, which is also found in the brand name sleep aids Intermezzo, Edluar and Zolpimist. It is a prescription medication used to treat insomnia. The study involved the evaluation of nearly 7,000 patients 65 and older who had never been diagnosed with Alzheimer’s disease. Half were prescribed zolpidem and the other half were not. Among the group taking zolpidem, 71 percent were taking what ... Read More
Auxilium Pharmaceuticals Inc., maker of the testosterone replacement therapy Testim, escaped a verdict in the first bellwether trial blaming Testim for a man’s heart attack. This marks the first victory in multidistrict litigation (MDL) over testosterone side effects that names several testosterone manufacturers. The first two bellwether trials were against AbbVie Inc., makers of AndroGel, and resulted in combined $290 million in verdicts. The seven-day trial focused on the case of Steve Holtsclaw, who claimed he was prescribed Testim after complaining to his doctor about chronic fatigue. Months after treatment, Holtsclaw suffered a heart attack. He since learned that studies ... Read More
There are many reasons people experience hair loss. Some men and women experience pattern baldness, which is genetic and often associated with aging. Some lose their hair as a side effect of toxic drugs such as chemotherapy. This type of hair loss is generally expected to be temporary, but for some cancer survivors their hair never grows back. Many are women who used Taxotere to treat breast cancer. Others, like 17-year-old Madisyn Babcock, have autoimmune disease alopecia areata, which causes patchy hair loss and in extreme cases total loss of hair on the scalp, face and even body. No matter ... Read More
More than 40 percent of adolescents decided to take dietary supplements on their own, while 30 percent decided to take the products based on the recommendation of parents or other family members. Yet, these teens are taking supplements without knowledge of harmful effects or drug interaction, according to a new study conducted by members of the Biotechnical Faculty at the University of Ljubljana in Slovenia. “According to the existing information, adolescents are the most susceptible and misinformed group of customers; thus this population is the target market for dietary supplements,” researchers said, according to Science Daily. The study involved 1,500 ... Read More
Steve Holtsclaw’s heart attack in 2014 weighs on his mind daily. He’s more emotional now, and constantly wonders, “How much longer have I got?” the 62-year-old man told an Illinois federal jury during the first bellwether trial in a multidistrict litigation (MDL) involving cardiovascular risks with Auxilium Pharmaceuticals Inc.’s testosterone replacement therapy Testim. Holtsclaw was prescribed Testim in 2013 after complaining to his doctor about chronic fatigue. A blood test showed his testosterone levels were low. Months later, Holtsclaw suffered a heart attack. He received two stents and was put on several medications to help prevent a second heart attack. ... Read More
Kentucky Attorney General Andy Beshear is suing Endo Pharmaceuticals alleging the company used fraudulent and deceptive marketing of its opioid painkiller Opana ER, a medication so prone to abuse that the Food and Drug Administration (FDA) pressured the company to pull it off the market. “Endo put its profits above the lives of our people and above patient safety,” Beshear said. The lawsuit states that only two percent of overdose deaths in 2010 were due to oxymorphone, the active drug ingredient in Opana ER. But the following year, that number soared to 23 percent. Beshear said that the deaths were ... Read More
U.S. District Judge Ed Kinkeade refused to allow jurors in a trial over alleged defective hip implants manufactured by Johnson & Johnson’s DePuy Orthopaedics to hear testimony related to alleged witness tampering involving communication between a DePuy attorney and a company pharmaceutical sales representative. The ruling comes after an investigation by the FBI and the U.S. Attorney’s Office into allegations that DePuy sales representative Glenn Swajger influenced David Shein, a surgeon who had treated three of the six plaintiffs, when the two conversed just days before Shein was to testify for the plaintiffs. Swajger agreed to be questioned by the ... Read More
Injectable silicone used to enhance or augment the body can lead to ongoing pain, infections, and serious injuries including scarring and permanent disfigurement, embolism, stroke and death, the Food and Drug Administration (FDA) warned in a Safety Communication. The agency added that injectable silicone has not been found safe or effective for this use. Silicone oil is a liquid polymer of siloxane that is used in lubricants and caulking materials. Injectable silicone is different from the silicone used to fill FDA-approved breast implants. The only FDA-approved use for injectable silicone is silicone oil used for specific conditions of the eye. ... Read More